This is a licensed product of Ken Research and should not be copied

Transcription

1 1

2 TABLE OF CONTENTS 1. The US Diabetes Care Devices Market Introduction 1.1. What is Diabetes and it s Types? 2. The US Diabetes Care Devices Market Size, The US Diabetes Care Devices Market Segmentation, By Blood Sugar Monitoring Devices, CGM Devices and Insulin Delivery Devices, The US Self Blood Glucose Monitoring Devices Market Introduction The US Self Blood Glucose Monitoring Devices Market Size, The US Self Blood Glucose Monitoring Devices Market Segmentation by Blood Glucose Meters, Blood Glucose Test Strips and Lancets and Lancing Devices, The US Blood Glucose Meters Market Size, Market Share of Major Players in the US Blood Glucose Meters Market, The US Blood Glucose Test Strips Market Size, Market Share of Major Players in the US Blood Glucose Test Strips Market, The US Lancets and Lancing Devices Market Size, Market Share of Major Players in the US Lancets and Lancing Devices Market, The US SMBG Devices Market Future Outlook and Projections, The US CGM Systems Market Introduction The US CGM Systems Market Size, Market Share of Major Players in the US CGM Systems Market, The US CGM Systems Market Future Outlook and Projections of, The US Insulin Delivery Devices Market Size and Introduction, The US Insulin Delivery Devices Market Segmentation by Insulin Pens, Insulin Syringes, Insulin Pumps, The US Insulin Pens Market Size,

3 Market Share of Major Players in the US Insulin Pens Market, The US Insulin Pumps Market Size, Market Share of Major Players in the US Insulin Pumps Market, The US Insulin Syringe Market Size, Market Share of Major Players in the US Insulin Syringe Market, The US Insulin Delivery Devices Market Future Outlook and Projections, Cause & Effect Relationship Analysis in the US Diabetic Care Devices Industry 4. Artificial Pancreas - The Ultimate Goal 5. Trends and Developments in the US Diabetic Care Devices Market 6. Prevalence of Diabetes across the US States 7. Patents Scenario in the US Diabetic Therapeutic Market 8. Strategic Partnerships and Acquisitions in the US Diabetic Market 9. The US Diabetic Care Devices Market SWOT Analysis 10. Company Profiles of Major Players in the US Diabetic Care Devices Market 11. The US Diabetic Care Devices Market Future Outlook and Projections, The US Macro Economic Indicators: Current and Projections Ageing Population in the US, Consumer Healthcare Expenditure, Diabetic Population in the US, Appendix Market Definitions Abbreviations Research Methodology Data Collection Methods Approach Variables (Dependent and Independent) 3

4 Multi Factor Based Sensitivity Model Final Conclusion Disclaimer 4

5 LIST OF FIGURES Figure 1: The US Diabetic Care Devices Market Size by Revenue in USD Million, Figure 2: The US Diabetic Care Devices Segmentation by SMBG devices, CGM devices and Insulin Delivery Systems on the Basis of Revenue in Percentage (%), Figure 3: The US Self Monitoring Blood Glucose Devices Market Size by Revenue in USD Million, Figure 4: The US SMBG Devices Segmentation by Glucose Meters, Blood Glucose Test Strips and Lancets and Lancing Devices on the Basis of Revenue in Percentage (%), Figure 5: The US Blood Glucose Meters Market Size by Revenue in USD Million, Figure 6: Market Share of Major Players in the US Blood Glucose Meters Market on the Basis of Revenue in Percentage (%), 2012 Figure 7: The US Blood Glucose Test Strips Market Size by Revenue in USD Million, Figure 8: Market Share of Major Players in the US Blood Glucose Test Strips Market on the Basis of Revenue in Percentage (%), 2012 Figure 9: The US Lancets and Lancing Devices Market Size by Revenue in USD Million, Figure 10: Market Share of Major Players in the US Lancets and Lancing Devices Market on the Basis of Revenue in Percentage (%), 2012 Figure 11: The US SMBG Market Future Projections on the Basis of Revenue in USD Million, Figure 12: The US Continuous Glucose Monitoring Systems Market Size by Revenue in USD Million, Figure 13: Market Share of Major Players in the US CGM systems Market on the Basis of Revenue in Percentage (%), 2012 Figure 14: The US CGM Systems Future Projections on the Basis of Revenue in USD Million, Figure 15: The US Insulin Delivery Devices Market Size by Revenue in USD Million,

6 Figure 16: The US Insulin Delivery Devices Segmentation by Insulin Pen, Insulin Syringe and Insulin Pump on the Basis of Revenue in Percentage (%), Figure 17: The US Insulin Pens Market Size by Revenue in USD Million, Figure 18: Market Share of Major Players in the US Insulin Pens Market on the Basis of Revenue in Percentage (%), 2012 Figure 19: The US Insulin Pumps Market Size by Revenue in USD Million, Figure 20: Market Share of Major Players in the US Insulin Pumps Market on the Basis of Revenue in Percentage (%), 2012 Figure 21: The US Insulin Syringe Market Size by Revenue in USD Million, Figure 22: Market Share of Major Players in the US Insulin Syringe Market on the Basis of Revenue in Percentage (%), 2012 Figure 23: The US Insulin Delivery Devices Market Future Projections on the Basis of Revenue in USD Million, Figure 24: The US Diabetic Care Devices Market Future Projections by Insulin Delivery Systems, CGM devices and SMBG Device on the Basis of Revenue in Percentage (%), Figure 25: The US Ageing Population in Million and the Proportion of Population above 65 Years as a Percentage (%) of Total Population, Figure 26: The US Healthcare Expenditure in USD Billion, Figure 27: Diabetes Patients in the US in Million,

7 LIST OF TABLES Table 1: Standard Blood Glucose Levels in the Human Body Table2: The US Diabetic Care Devices Market Segmentation by SMBG devices, CGM devices and Insulin Delivery Systems on the Basis of Revenue in USD Million, Table 3: The US SMBG Devices Market Segmentation by Glucose Meters, Blood Glucose Test Strips and Lancets and Lancing Devices on the Basis of Revenue in USD Million, Table 4: The US Insulin Delivery Devices Market Segmentation by Insulin Pen, Insulin Syringe and Insulin Pump on the Basis of Revenue in USD Million, Table 5: Advantages and Disadvantages of Different Types of Insulin Delivery Devices Table 6: Cause and Effect Relationship between the Dependent and Independent Variables Prevailing in the US Diabetic Care Devices Market Table 7: Alternate modes of Insulin Delivery Table 8: Top Ten States with the Highest Obesity Rates in the US Table 9: Top Ten States with the Highest Rates of High Blood Pressure in the US Table 10: Top Ten States with the Highest Diabetes Rate in the US Table 11: Diabetic Patents in the US by Patent Number, Inventors, Filing Date and Publication Date Table 12: Acquisitions in the US Diabetic Market, Table 13: Strategic Partnerships in the US Diabetic Market, Table 14: Competitive Landscape of Major Players (Medtronics, Dexcom inc, Abbot laboratories, Roche Diagnostics, Insulet Corporation, LifeScan Inc, Novo Nordisk) in the US Diabetic Care Devices Market Table 15: The US Diabetic Care Devices Market Future Projections by Insulin Delivery Systems, CGM devices and SMBG Device on the Basis of Revenue in USD Million, Table 16: Healthcare Expenditure Pattern of US Adults by Contribution in Percentage (%), 2012 Table 17: Type I and Type II Diabetes Population in the US in Million, Table 18: Correlation Matrix of the US CGM Devices Market Table 19: Regression Coefficients Output of the US CGM Devices Market 7

8 THE US DIABETES CARE DEVICES MARKET SIZE, The US Diabetic Care Devices market recorded a ~ % during the period The market was worth USD ~ million in It grew by 5.1% in value terms in the year This industry has been largely driven by the surging demand for diabetic care devices by the middle aged and young adult population due to rising incidence of obesity and reduced physical activity The wide acceptance of vast array of diabetic care devices has led to the growth of the diabetic care devices market in the country in the recent years. It has been witnessed that there has been an increasing likelihood towards new innovative diabetic products and the consumption pattern of traditional diabetic products, for example, insulin syringe; glucose monitoring devices is showing a declining trend Figure: The US Diabetic Care Devices Market Size by Revenue in USD Million, , , ,000.0 USD Million 6, , , P 8

9 THE US DIABETES CARE DEVICES MARKET SEGMENTATION, BY BLOOD SUGAR MONITORING DEVICES, CGM DEVICES AND INSULIN DELIVERY DEVICES, The diabetic care devices market is largely dominated by two sub markets, self monitoring glucose devices and insulin delivery devices. SMBG devices includes glucose meters, test strips and lancets and lancing devices which are increasingly becoming commoditized products and have led to strong price competition CGM devices continue to demonstrate augmenting product innovations and price premiums SMBG devices recorded a growth of ~% in The insulin delivery devices landscape is likely to propose strong growth opportunities through 2018, given the heap of opportunities for introduction of advanced products such as insulin inhalers in the market. SMBG devices, marking a contribution of nearly ~ % as recorded in 2013 The insulin delivery devices accounted for approximately ~ % of the diabetic care devices revenue in the country in the year The consumption trend of insulin syringe has been declining while insulin pens and insulin pumps are showcasing an increasing trend. Although, the latter products are more expensive than the former, an increasing trend for the latter is driving up the revenue of the market The US is a leading in the CGM market in terms of revenue generation. The US Diabetic Care Devices Segmentation by SMBG devices, CGM devices and Insulin Delivery Systems on the Basis of Revenue in Percentage (%), Percentage (%) 100.0% 90.0% 80.0% 70.0% 60.0% 50.0% 40.0% 30.0% 20.0% 10.0% 0.0% P 9

10 THE US BLOOD GLUCOSE METERS MARKET SIZE, Blood Glucose meters are small computerized machines that display blood glucose levels as a number on the screen Growing prevalence of diabetes in the country and availability of blood glucose meters at nominal prices will drive the revenue of the market in the future. The market was valued at USD ~ million in 2013 compared to USD ~ million in 2007, recording a CAGR growth of ~ % during this period... The market grew at a declining rate of ~% from , owing to the global economic crises. Roche Diagnostics, LifeScan, Abbott Diabetes Care and Bayer Healthcare are key players in this market segment. Figure: The US Blood Glucose Meters Market Size by Revenue in USD Million, USD Million P MARKET SHARE OF MAJOR PLAYERS IN THE US BLOOD GLUCOSE TEST STRIPS MARKET, 2012 The US Blood Glucose test strips market is concentrated among few large players contributing nearly ~% to the overall SMBG test strips market in the US in Brands such as Accu Chek, FreeStyle and others are capitalizing on the lifestyle shift of the US consumers towards health and fitness LifeScan accounted for a share of ~% in the US glucose test strips market in 2012 Abbott Diabetes Care held a ~% market share 10

11 Market Share of Major Players in the US Blood Glucose Test Strips Market on the Basis of Revenue in Percentage (%), 2012 LifeScan Roche Diagnostics Bayer Abbott Others THE US CGM SYSTEMS MARKET SIZE, CGM systems market in the nation has grown steadily over the period The industry reached USD ~ million in 2013 from USD ~ million in 2010, showing a phenomenal growth, recording an impressive CAGR of ~% from This exceptional growth has been triggered by rising population, surging old age population and increasing healthcare expenditure on diabetic care devices...with the compelling business potential and economies of scale possessed by the market, it is expected that several domestic and international players will expand into the US CGM systems market in the near term 11

12 Figure: The US Continuous Glucose Monitoring Systems Market Size by Revenue in USD Million, USD Million P THE US INSULIN DELIVERY DEVICES MARKET SEGMENTATION BY INSULIN PENS, INSULIN SYRINGES, INSULIN PUMPS, Insulin pens contributed nearly ~% to the overall insulin delivery systems market sales in 2013, recording sales of USD ~ million. The market in the recent years has witnessed a surge in the demand for insulin pens from Type II diabetic patients... Insulin syringe contributed ~% to the aggregate insulin delivery devices market. The share of this device has declined over the years due to the launch of potential diabetic device substitutes such as insulin pens and artificial pancreas The insulin pump market is another leading product category in the insulin delivery devices market in the nation, recording USD ~ million in Its contribution in insulin delivery market segment was ~% in It is a relatively new diabetic device, introduced in the domestic market in the recent years, and has gained popularity amongst the masses owing to increased accuracy and convenience in using this device. 12

13 Figure: The US Insulin Delivery Devices Segmentation by Insulin Pen, Insulin Syringe and Insulin Pump on the Basis of Revenue in Percentage (%), % 90.0% 80.0% Percentage (%) 70.0% 60.0% 50.0% 40.0% 30.0% 20.0% 10.0% 0.0% P MARKET SHARE OF MAJOR PLAYERS IN THE US INSULIN PUMPS MARKET, 2012 Continuous subcutaneous insulin infusion via an insulin pump is apparently more convenient and flexible mode of insulin delivery when compared to pen injected insulin and syringe injected insulin. Insulin pumps are expected to generate higher revenue in the forthcoming times. In 2009, nearly ~ diabetic patients were using insulin pumps.. Medtronic held a market share of ~% in Animus Corporation, a part of Johnson & Johnson Diabetes franchise, captured ~% of the insulin pumps market in the nation in 2012 Other local medical device companies held a market share of ~% as recorded in

14 Figure: Market Share of Major Players in the US Insulin Pumps Market on the Basis of Revenue in Percentage (%), 2012 Medtronic Animus Others THE US INSULIN DELIVERY DEVICES MARKET FUTURE OUTLOOK AND PROJECTIONS, Devoid of any anticipated significant changes in public and private strategies, the increasing incidence of diabetes and associated cost growth will add more strain to the already overburdened healthcare system The baby boom generation is becoming aged while the aged population is accompanied by costly chronic diseases... In light of this; policymakers are The increasing incidence of diabetes and its associated cost growth will add more strain to the already overburdened healthcare system. developing policies that will help curb the expected rise in diabetes burden. The growth of the insulin delivery devices in the nation is dependent on the demographic shifts in the population, trends in obesity, trends and dissemination of diabetes related ailments and diagnostic tests. Insulin Delivery Devices are available across the country The market is expected to grow at a CAGR of ~% in the coming years, , with the market size reaching USD ~ million in 2018 from USD ~ million in

15 DISCLAIMER The research reports provided by Ken Research are for the personal information of the authorized recipient and is not for public distribution and should not be reproduced or redistributed without prior permission. You are permitted to print or download extracts from this material for your personal use only. None of this material may be used for any commercial or public use. The information provided in the research documents is from publicly available data and other sources, which are reliable. Efforts are made to try and ensure accuracy of data. With respect to documents available, neither the company nor any of its employees makes any warranty, express or implied, including the warranties of merchantability and fitness for a particular purpose, or assumes any legal liability or responsibility for the accuracy, completeness, or usefulness of any information, apparatus, product, or process disclosed, or represents that its use will not infringe privately owned rights. The report also includes analysis and views expressed by our research team. The research reports are purely for information purposes. The opinions expressed are our current opinions as of the date appearing in the material and may be subject to change from time to time without notice. Investors should not solely rely on the information contained in the research documents and must make investment decisions based on their own investment objectives, risk profile and financial position. The recipients of this material should take their own professional advice before acting on this information. Ken Research will not accept returns of reports once dispatched due to the confidentiality of information provided in our reports. In case, a report qualify for return, we will issue a credit, minus shipping charges, of equal value to the original purchase price, toward a future purchase no refunds. The decision about whether the product return can be accepted or not is solely at our discretion. Any dispute will be subject to laws of India and exclusive jurisdiction of Indian Courts. No part of this manual or any material appearing may be reproduced, stored in or transmitted on any other Web site without written permission of Ken Research and any payments of a specified fee. Requests to republish any material may be sent to us. 15